Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808872 · ClinicalTrials.gov registry record
Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP
A clinical trial, sponsored by Radiometer Medical ApS.
- Completed
- Registry status
- 569
- Enrollment target
NCT01808872 is a clinical trial that has completed, run by Radiometer Medical ApS. The registered enrollment target is 569 participants.
The verdict
NCT01808872 has completed, sponsored by Radiometer Medical ApS.
- COMPLETED
- Registry status
- 569 participants
- Enrollment target
Study Summary
The AQT90 FLEX B-type Natriuretic Peptide (BNP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) Tests are in vitro diagnostic assays intended as an aid in the diagnosis and assessment of the severity of heart failure in point-of-care and laboratory settings. The purpose of the study is to establish the clinical performance of the AQT90 FLEX BNP and NT-proBNP assays for both whole blood and plasma in the intended use population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 569 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01808872
The ClinicalTrials.gov registry entry for NCT01808872 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 569 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiometer Medical ApS, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01808872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01808872 about?
NCT01808872 is a clinical study titled "Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP". The AQT90 FLEX B-type Natriuretic Peptide (BNP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) Tests are in vitro diagnostic assays intended as an aid in the diagnosis and assessment of the severity of heart failure in point-of-care and laboratory settings. The purpose of the study is to ...
What is the current status of trial NCT01808872?
This trial is currently completed. The enrollment target is 569 participants. The study started on 2013-03. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT01808872?
This trial is sponsored by Radiometer Medical ApS, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.